| |
| |
|
|
A BILL TO BE ENTITLED
|
|
|
AN ACT
|
|
|
relating to a study regarding the provision of certain medications |
|
|
through the Medicaid vendor drug program to children younger than |
|
|
16 years of age. |
|
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
|
SECTION 1. Subchapter B, Chapter 531, Government Code, is |
|
|
amended by adding Section 531.0731 to read as follows: |
|
|
Sec. 531.0731. STUDY REGARDING THE PROVISION OF CERTAIN |
|
|
MEDICATION TO CHILDREN. (a) The commission shall conduct a study |
|
|
to determine the appropriateness and safety of providing |
|
|
antipsychotic or neuroleptic medication through the Medicaid |
|
|
vendor drug program to children younger than 16 years of age. |
|
|
(b) The study conducted under Subsection (a) must consider |
|
|
the following factors relevant to the appropriateness and safety of |
|
|
providing the medications to children: |
|
|
(1) the physical and psychological medical diagnosis |
|
|
of a child's condition; |
|
|
(2) whether the United States Food and Drug |
|
|
Administration has approved a medication for use by a child of a |
|
|
certain age; |
|
|
(3) whether a child has successfully taken a |
|
|
medication previously; and |
|
|
(4) any other factor the commission considers |
|
|
relevant. |
|
|
(c) Not later than November 10, 2010, the executive |
|
|
commissioner shall submit a report containing the results of the |
|
|
study conducted under Subsection (a) to the governor, lieutenant |
|
|
governor, speaker of the house of representatives, and the chairs |
|
|
of the Senate Committee on Health and Human Services and the House |
|
|
Committee on Public Health. |
|
|
SECTION 2. This Act takes effect September 1, 2009. |